You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins

    SBC: AMBERGEN, INC            Topic: N/A

    DESCRIPTION (provided by applicant): There exists an urgent need to develop an effective, non-invasive method of detecting colorectal cancer (CRC), the second leading cause of cancer deaths in the U.S. Such non-invasive testing, if instituted for a large segment of the population, could result in a dramatic reduction in the approximately 56,000 annual deaths caused by CRC. However, current methods ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  2. Advanced Molecular Diagnostic Test for Neurofibromatosis

    SBC: AMBERGEN, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Advanced Molecular Diagnostic Test for Neurofibromatosis ABSTRACT Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder caused by mutations in the NF1 gene. In children, NF1 causes learning disabilities, coordination problems and benign tumors later in life that grow on nerve tissue. Currently more than 100,000 Americans suffer from NF1 with the dise ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  3. Targeted tumoricidal bacteria

    SBC: ANTICANCER, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this application is to develop imageable tumor-targeting bacteria that can cure tumors without progressive infection of the host. Previous experiments by others employed anaerobic microorganisms for cancer therapy. Target specificity appeared largely due to the anaerobic requirements met principally in necrotic tumor areas. The resulting tumor killi ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Alkylating Vitamin D Derivative

    SBC: APHIOS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US. There are currently no approved therapies for hormone-refractory prostate cancer. Epidemiological studies have demonstrated a strong relationship between incidence of and mortality from various cancers including prostate cancer, exposure to ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  5. A Device to Assess Sleep Breathing in Children at Home

    SBC: APNEOS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Sleep-related breathing disorders (SRBDs), such as sleep apnea, take a heavy public health toll, especially on children. Mounting evidence suggests that these disorders can impact physical and mental development. Diagnosing and understanding these disorders are major challenges. Polysomnography, an imperfect gold standard, is not practical to apply on a wide ba ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  6. Gridless Simulation of Flow-MPHV Interaction

    SBC: Applied Scientific Research            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this project is to develop a CFD software for the grid-free simulation and analysis of the complex dynamics of the Fluid-Structure Interaction (FSI) associated with Mechanical Prosthetic Heart Valve (MPHV) "systems" as they respond to physiologically realistic 3-D pulsatile flow. The final product will be the first commercially available grid-f ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  7. Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer

    SBC: ARAVASC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Airways can be obstructed by a variety of diseases resulting in breathing difficulties and compromised quality of life for the patients. Lung cancer is one of the major diseases causing airway obstruction. According to the American Cancer Society it is the single largest cause of cancer deaths in the United States (173,000 estimated new cases diagnosed in 2006) ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  8. Human Monoclonal Antibody To Treat P. aeruginosa Infections in Cystic Fibrosis

    SBC: Aridis Pharmaceuticals, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Cystic Fibrosis (CF) is an autosomal recessive disorder, which leads to the abnormal composition and physical properties of airway secretions in CF patients. Additionally, the lungs of CF patients are particularly susceptible to chronic bacterial infections with >80% of CF patients becoming chronically infected by 18 years of life with mucoid forms of Pseudomon ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  9. Recombinant Enzyme Fusion Protein for Lysosomal Storage Disorders

    SBC: ARMAGEN TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Zhang, Yun Abstract There are over 40 lysosomal storage disorders, and most of these diseases affect adversely the central nervous system (CNS). The mainstay of treatment is enzyme replacement therapy (ERT). However, ERT is not effective for the brain, because the enzymes do not cross the brain capillary wall, which forms the blood-brain barrier (BBB) in vivo. ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  10. Magnetic Encoded Sortable Particle Arrays

    SBC: ARRAYOMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The aim of this project is to develop a novel 'liquid array' platform, based on Encoded Sortable Particle (ESP) technology. ESPs are optically-encoded microfabricated particles that can be manipulated using magnetic force. They are manufactured on commercially available photolithographic equipment using efficient and robust techniques borrowed from the semi-con ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government